We write

The domestic pharmaceutical companies, which are sponsors of clinical researches, must develop of procedures and documentation for effective control of quality of clinical researches of medical products.
For what are needed Bioequivalence Study? First of all, this is professional instrument: obtainable information about therapeutic generic’s equivalence makes it possible for specialists to use with evidence interchangeable medicines etc. Secondly, it permits to cut down expenses, when generis are using, but affectivity and drug safety is stay. The results of clinic study of bioequivalence medicines include by Meldonium observed.
Main GLP requirements applicable on Bioequivalence and Pharmacokinetic Study of Medicines and conferment of Bioanalytical Laboratory “Clinfarm” were observed in this article
Share in social networks: